Osaic Holdings
TLIS

Osaic Holdings’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

Osaic Holdings’s Portfolio TLIS Stock Details TLIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-84
Closed -$727 – 7613
2024
Q2 		$727 Sell
84
-38
-31% -$337 ﹤0.01% 6896
2024
Q1 		$1.07K Buy
122
+17
+16% +$140 ﹤0.01% 6667
2023
Q4 		$782 Sell
105
-67
-39% -$437 ﹤0.01% 6818
2023
Q3 		$992 Buy
172
+68
+65% +$465 ﹤0.01% 6828
2023
Q2 		$751 Hold
104
– – ﹤0.01% 6953
2023
Q1 		$766 Hold
104
– – ﹤0.01% 7039
2022
Q4 		$0 Sell
104
-29
-22% -$254 ﹤0.01% 7491
2022
Q3 		$2K Hold
133
– – ﹤0.01% 6869
2022
Q2 		$2K Hold
133
– – ﹤0.01% 6962
2022
Q1 		$2K Sell
133
-10
-7% -$346 ﹤0.01% 6935
2021
Q4 		$9K Hold
143
– – ﹤0.01% 6362
2021
Q3 		$13K Buy
143
+66
+86% +$8.79K ﹤0.01% 6065
2021
Q2 		$13K Hold
77
– – ﹤0.01% 5923
2021
Q1 		$15K Buy
+77
New +$19.2K ﹤0.01% 5666

Other funds holding TLIS

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Osaic Holdings's TLIS Position: Q3 2024 in Review

Osaic Holdings sold out of Talis Biomedical Corporation Common Stock (TLIS) in Q3 2024, closing a stake of 84 shares — an estimated $727 sold.

Osaic Holdings first reported a position in TLIS in Q1 2021 and held it in 14 quarters. The position peaked at $15K in Q1 2021. 2 funds tracked by Wall St. Rank hold TLIS as of Q3 2024.

  • Osaic Holdings reported no remaining Talis Biomedical Corporation Common Stock position as of Q3 2024 after selling out during the quarter.
  • Osaic Holdings sold 84 Talis Biomedical Corporation Common Stock shares in Q3 2024, an estimated $727.
  • Osaic Holdings first reported a position in Talis Biomedical Corporation Common Stock in Q1 2021 and held it in 14 quarters.
  • Osaic Holdings's Talis Biomedical Corporation Common Stock position peaked at $15K in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q3 2024.

Based on Osaic Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.